Rare diseases
Investigational molecules
Locations
Study of antibiotic treatment effectiveness in critically ill patients receiving drug combination therapy
FranceStudy of pivmecillinam compared to standard antibiotics for treating Escherichia coli urinary tract infection with fever
NorwayComparison of Gentamicin with Narrow-Spectrum Antibiotics versus Broad-Spectrum Antibiotics in Adult Patients with Early Sepsis
NorwayStudy on High-Dose Short-Course Antibiotics for Critically Ill Patients with Pneumonia, Intra-Abdominal, or Bloodstream Infections: Ceftriaxone, Linezolid, and Cefotaxime
BelgiumStudy on the Effectiveness of Clarithromycin and Other Drug Combinations for Patients with Uncomplicated Staphylococcus aureus Blood Infection
DenmarkStudy Comparing Dalbavancin to Standard Antibiotics for Patients with Staphylococcus aureus Bloodstream Infections
FranceStudy on Optimizing Initial Dosing of Flucloxacillin and Drug Combination for Critically Ill Patients with Sepsis in the ICU
The NetherlandsStudy on Customized Antibiotic Treatment Duration for Hospitalized Patients with Community-Acquired Pneumonia Using Cefotaxime and Drug Combination
FranceStudy on Oral Antibiotics Moxifloxacin, Linezolid, and Metronidazole for Patients with Bacterial Brain Abscess
DenmarkStudy on Shortened Antibiotic Treatment for Infectious Endocarditis Using Vancomycin, Meropenem, and Ceftriaxone for Patients with Left-Sided Heart Infection
SwedenFosfomycin trometamol versus drug combination for treating acute E. coli pyelonephritis in women aged 75 years and older
FranceIndividualized beta‑lactam dosing with piperacillin (drug combination) for ICU patients with sepsis caused by gram‑negative bacteria
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
